Analysts Viewpoint
ImmunityBio Inc (IBRX) receives a Neutral rating from Piper Sandler
Following these proceedings, Piper Sandler downgraded its ImmunityBio Inc [IBRX] rating to a Neutral from a an Overweight in a
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.